Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 62/193,518, filed Jul 16, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,655,857 | Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor In force · High confidence | Pharmacyclics LLC | In force | High confidence | ||
| US 10,010,507 | Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 10,213,386 | Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | ||
| US 10,828,259 | Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | ||
| US 12,551,448 | Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor In force · Low confidence | Pharmacyclics LLC | In force | Low confidence | ||
| Application 15/467,414 | Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor Abandoned Abandoned Jan 26, 2018 | Pharmacyclics LLC | Abandoned | Abandoned Jan 26, 2018 | ||
| Application 16/128,312 | Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor Abandoned Abandoned Sep 25, 2019 | Pharmacyclics LLC | Abandoned | Abandoned Sep 25, 2019 | ||
| Application 16/228,682 | Pharmaceutical Formulations of a Brutons Tyrosine Kinase Inhibitor Abandoned Abandoned Sep 15, 2019 | Pharmacyclics LLC | Abandoned | Abandoned Sep 15, 2019 | ||
| Application 17/536,701 | Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor Abandoned Abandoned Nov 14, 2024 | Pharmacyclics LLC | Abandoned | Abandoned Nov 14, 2024 |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.